<?xml version="1.0" ?>
<document id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce">
  <chunk id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c0" text="Exogenous lipoid pneumonia: an important cause of interstitial lung disease in infants">
    <entity charOffset="50-75" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c0.e0" ontology_id="HP_0006530" text="interstitial lung disease" type="phenotype"/>
    <entity charOffset="63-75" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c0.e1" ontology_id="HP_0002088" text="lung disease" type="phenotype"/>
  </chunk>
  <chunk id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1" text="Exogenous lipoid pneumonia (ELP), an important cause of interstitial lung disease, often goes unrecognized. We conducted a retrospective study of children with histologically confirmed ELP at Red Cross Children's Hospital, South Africa. Twelve children of Zimbabwean heritage aged 2.1-10.8 months were identified between 2012 and 2017. Repeated oral administration of plant-based oil for cultural reasons was reported by 10 of 11 caregivers. Cough (12/12), tachypnoea (11/12), hypoxia (9/12), and diffuse alveolar infiltrates on chest radiography (12/12) were common at presentation. Chest computed tomography revealed ground-glass opacification with lower zone predominance (9/9) and interlobular septal thickening (8/9). Bronchoalveolar lavage specimens appeared cloudy/milky, with abundant lipid-laden macrophages and extracellular lipid on Oil-Red-O staining (12/12), with polymicrobial (6/12) and Mycobacterium abscessus (2/12) coinfection. Antibiotics, systemic corticosteroids, and therapeutic lavage were interventions in all eight and five patients, respectively. Clinicians should consider ELP in children with non-resolving pneumonia in settings with similar practices.">
    <entity charOffset="17-26" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e0" ontology_id="HP_0002090" text="pneumonia" type="phenotype"/>
    <entity charOffset="56-81" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e1" ontology_id="HP_0006530" text="interstitial lung disease" type="phenotype"/>
    <entity charOffset="442-447" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e2" ontology_id="HP_0012735" text="Cough" type="phenotype"/>
    <entity charOffset="477-484" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e3" ontology_id="HP_0012418" text="hypoxia" type="phenotype"/>
    <entity charOffset="497-504" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e4" ontology_id="HP_0020034" text="diffuse" type="phenotype"/>
    <entity charOffset="821-834" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="1135-1144" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e6" ontology_id="HP_0002090" text="pneumonia" type="phenotype"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e0" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p0" relation="true"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e1" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p1" relation="true"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e2" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p2" relation="true"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e3" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p3" relation="true"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e4" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p4" relation="true"/>
    <pair e1="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e5" e2="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.e6" id="af989f3b3f8bf8e0b3d8da323e3443a3f50ca2ce.c1.p5" relation="true"/>
  </chunk>
</document>
